van Beek W, Vernole P, Neri G
Eur J Cancer Clin Oncol. 1983 Apr;19(4):553-9. doi: 10.1016/0277-5379(83)90121-9.
The appearance of a class of fast-eluting cell-surface glycopeptides that are encountered almost exclusively in malignant and certain pre-malignant cells was monitored in the course of leukemogenesis in the thymus of rats injected at birth with Gross leukemia virus. The altered glycopeptides appeared as early as 15 days after virus injection, when the animals were still clinically healthy and no histological signs of the disease were present in the thymus. Their amount was further increased at 30 days, and reached a maximum in the fully developed lymphoma. The development of this early phenotypic marker of malignancy appeared to be concomitant with that of chromosomal anomalies in the thymus. Since these anomalies are non-random, the existence of a causal relationship between the glycopeptide change and the loss of specific chromosomes might be hypothesized.
在给新生大鼠注射格罗斯白血病病毒后,于大鼠胸腺白血病发生过程中,监测了一类几乎仅在恶性细胞和某些癌前细胞中出现的快速洗脱细胞表面糖肽的出现情况。早在注射病毒后15天,这些改变的糖肽就出现了,此时动物在临床上仍很健康,胸腺中也没有该疾病的组织学迹象。在30天时它们的数量进一步增加,并在完全发展的淋巴瘤中达到最大值。这种早期恶性表型标志物的发展似乎与胸腺中染色体异常的发展同步。由于这些异常是非随机的,因此可以推测糖肽变化与特定染色体丢失之间存在因果关系。